Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ranolazine in Ischemic Cardiomyopathy Patients With Persistent Chest Pain or Dyspnea Despite Conventional Therapy: A Cross-Over Study

NCT01345188 is registered in ClinicalTrials.gov with Midwest Cardiovascular Research Foundation as lead sponsor.

NCT NCT01345188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01345188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ranolazine in Ischemic Cardiomyopathy Patients With Persistent Chest Pain or Dyspnea Despite Conventional Therapy: A Cross-Over Study
Lead sponsor
Midwest Cardiovascular Research Foundation
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2011
Completion date
April 30, 2014
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiomyopathy, chest pain, dyspnea